Bioscience startup HemaSense of Flagstaff was one of three companies to earn a cash prize in the 2025 Venture Madness by Invest Southwest competition held earlier this month in Tempe.
HemaSense is improving patient outcomes and reducing costs of percutaneous interventions by providing health care professionals the first early alert system for bleeding complications at the access site during post-op recovery, according to its website.
HemaSense was awarded second place and $7,500 in the 16-startup pitch competition. The 16 early-stage companies were selected from 125 applicants.